Evidence map›Paper›PMID 30324555›Full record

ArticleDigestive diseases and sciences2019

Proinflammatory Sulfur-Reducing Bacteria Are More Abundant in Colonic Biopsies of Patients with Microscopic Colitis Compared to Healthy Controls.

Valentine Millien, Daniel Rosen, Jason Hou, Rajesh Shah

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Microbiome Composition in Microscopic Colitis: A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Microscopic Colitis: Pathogenesis and Diagnosis.Journal of clinical medicine · 2023
    Review
  6. Article
  7. Article
  8. Transport stress affects the fecal microbiota in healthy donkeys.Journal of veterinary internal medicine · 2021
    Article
  9. Article
  10. Microscopic colitis.Nature reviews. Disease primers · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Fecal Microbiota Signatures in Celiac Disease Patients With Poly-Autoimmunity.Frontiers in cellular and infection microbiology · 2020
    Article
  16. Management of microscopic colitis: challenges and solutions.Clinical and experimental gastroenterology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Valentine MillienDepartment of Medicine, Baylor College of Medicine, 2002 Holcombe Blvd MCL-111D, Houston, TX, 77030, USA.ORCID 0000-0002-8891-7344
Daniel RosenDepartment of Pathology, Baylor College of Medicine, Houston, TX, USA.
Jason HouDepartment of Medicine, Baylor College of Medicine, 2002 Holcombe Blvd MCL-111D, Houston, TX, 77030, USA.
Rajesh ShahDepartment of Medicine, Baylor College of Medicine, 2002 Holcombe Blvd MCL-111D, Houston, TX, 77030, USA. rajeshs@bcm.edu.
Baylor College of Medicine · USMichael E. DeBakey VA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMicroscopic colitis (MC), a subtype of inflammatory bowel disease, is a chronic condition of unknown etiology. Recent evidence has linked MC with intriguing changes in the stool microbiota, which may be linked to disease pathogenesis. The composition of the mucosal microbiome in patients with MC remains unclear.

methodsWe performed a cross-sectional study comparing colonic tissue samples from patients with MC to those of healthy controls at the Michael E. DeBakey VA Medical Center. We included adults older than 18 who underwent a colonoscopy with biopsies to evaluate chronic diarrhea. Cases were defined by histology consistent with MC and controls by the absence of histologic disease. We conducted structured chart review to exclude other gastrointestinal diseases and obtain demographic (age, sex, race) and clinical (duration of symptoms and concurrent medications) information for cases and controls. We extracted bacterial DNA from formalin-fixed paraffin-embedded tissue samples and sequenced the v4 region of the 16S rRNA gene. Operational taxonomic unit (OTU) clustering was performed using UPARSE, and OTUs were assigned using the SILVA database. Statistical analysis was performed in QIIME and LEfSe. Comparisons with FDR-adjusted p values of less than 0.05 were considered statistically significant.

resultsWe included 20 MC patients and 20 controls with mean ages of 62 and 54, respectively. Most cases were White (95%), 60% had symptoms for greater than 12 months, and 50% were taking PPIs and NSAIDs at the time of their diagnosis. Compared to controls, MC patients had a significant increase in the proinflammatory sulfur-reducing bacterial family Desulfovibrionales. The Coriobacteriaceae family, abundant in the healthy gut, was significantly decreased in MC cases. There was also an increase in the genus Actinomyces in MC patients on PPI and an increase in the class Bacilli among those taking NSAIDs. DISCUSSION: Patients with MC have an increase in the proinflammatory family Desulfovibrionales. Actinomyces and Bacilli were associated with medications (PPI and NSAID) known to increase the risk of MC. Our findings may have important implications for understanding the pathogenesis of MC.

Indexed as

ActinobacteriaActinomycesAdultAgedAged, 80 and overAnti-Inflammatory Agents, Non-SteroidalBacillusBiopsyCase-Control StudiesColitis, MicroscopicColonoscopyCross-Sectional StudiesDesulfovibrionalesFemaleGastrointestinal MicrobiomeHumansAnti-Inflammatory Agents, Non-SteroidalProton Pump InhibitorsRNA, Ribosomal, 16SDiarrheaMicrobiomeMicroscopic colitisSulfur-reducing bacteria

Identifiers

PMID30324555
OpenAlexW2896811720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.